5:11 PM
 | 
Apr 01, 2014
 |  BC Extra  |  Financial News

Intercept proposes follow-on

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) proposed to sell 600,000 shares in a follow-on underwritten by BofA Merrill Lynch; Citigroup; Goldman Sachs; Deutsche Bank; BMO Capital Markets; Needham; Oppenheimer; Wedbush PacGrow; JMP Securities; and Summer Street. If...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >